Korro Bio Revenue and Competitors
Estimated Revenue & Valuation
- Korro Bio's estimated annual revenue is currently $19.1M per year.
- Korro Bio's estimated revenue per employee is $165,783
- Korro Bio's total funding is $207.5M.
Employee Data
- Korro Bio has 115 Employees.
- Korro Bio grew their employee count by 10% last year.
Korro Bio's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-Founder | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Chief Legal Officer | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | VP, Head CNS Biology | Reveal Email/Phone |
6 | VP, Head Data Science | Reveal Email/Phone |
7 | VP, Head CMC | Reveal Email/Phone |
8 | SVP, Head Platform - RNA Editing | Reveal Email/Phone |
9 | VP, Head Data Science | Reveal Email/Phone |
10 | VP, HRBP, People & Culture | Reveal Email/Phone |
Korro Bio Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $5.2M | 67 | -45% | $107.3M | N/A |
#2 | $0.3M | 1 | -50% | N/A | N/A |
#3 | $5.1M | 33 | 22% | N/A | N/A |
#4 | $11.9M | 77 | -37% | $312.8M | N/A |
#5 | $0.9M | 2 | -60% | N/A | N/A |
#6 | $235M | 300 | -5% | $340.9M | N/A |
#7 | $45.9M | 237 | -7% | $7.6M | N/A |
#8 | $3.9M | 50 | 35% | N/A | N/A |
#9 | N/A | 11 | 10% | N/A | N/A |
#10 | $5.4M | 29 | 0% | N/A | N/A |
What Is Korro Bio?
Korro Bio was founded to turn extraordinary scientific insights into life-altering new treatments for patients. We harness the body's natural RNA editing machinery to make precise, single-base RNA edits to modulate protein function, addressing the medical needs of patients. Our mission is to rewrite the future for patients living with debilitating disease by repairing the underlying genetic cause.
keywords:N/A
$207.5M
Total Funding
115
Number of Employees
$19.1M
Revenue (est)
10%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Korro Bio News
The last couple of startups that you've helped found, Korro Bio and Triplet Therapeutics, both focus on RNA. I wonder if you can speak a...
Premium Cambridge-based biotech startup Korro Bio has raised $91.5 million in a Series A funding round led by Chinese investment firm Wu Capital to boost its gene-editing therapies. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Con ...
Premium Cambridge-based biotech startup Korro Bio has raised $91.5 million in a Series A funding round led by Chinese investment firm Wu Capital to boost its gene-editing therapies. Continue reading this story with a subscription to DealStreetAsia. Subscribe Already a subscriber? Log in Con ...
RNA therapeutics company Korro Bio announced recently that it has raised $91.5 million in a Series A funding round to advance its novel platform for precise and single-base RNA editing to modulate protein function for therapeutic applications RNA therapeutics company Korro Bio announced recentl ...
Other Companies in Cambridge
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $17.8M | 115 | 13% | $13.2M |
#2 | $3.5M | 116 | 23% | N/A |
#3 | $21.4M | 116 | 18% | N/A |
#4 | $15M | 116 | 33% | N/A |
#5 | $24.4M | 116 | 7% | N/A |